Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
The Digestives & Intestinal Remedies market in Georgia is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Digestives & Intestinal Remedies market in Georgia are shifting towards natural and herbal remedies. Customers are becoming more conscious about their health and are seeking products that are safe, effective, and have minimal side effects. This preference for natural remedies is driven by the belief that they are better for long-term health and well-being. As a result, there is a growing demand for natural digestive and intestinal remedies in the market.Trends in the Digestives & Intestinal Remedies market in Georgia include the increasing popularity of probiotics and digestive enzymes. Probiotics are live bacteria and yeasts that are good for the digestive system, while digestive enzymes help break down food and aid digestion. These products are gaining traction among consumers who are looking for solutions to improve their digestive health. Additionally, there is a rising trend of consumers seeking products that address specific digestive issues such as bloating, indigestion, and constipation.Local special circumstances in Georgia contribute to the development of the Digestives & Intestinal Remedies market. The country has a rich tradition of herbal medicine and natural remedies, which aligns with the current customer preferences. This cultural heritage has created a favorable environment for the growth of the market, as consumers are already familiar with and open to using natural remedies. Furthermore, the healthcare system in Georgia is evolving, with an increasing focus on preventive care and self-management of health issues. This has led to a greater emphasis on natural remedies and alternative therapies, including those for digestive and intestinal health.Underlying macroeconomic factors also play a role in the development of the Digestives & Intestinal Remedies market in Georgia. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and consumer spending. This has allowed consumers to allocate more of their budget towards healthcare and wellness products, including digestive and intestinal remedies. Additionally, the growing awareness of the importance of digestive health and the availability of a wide range of products have contributed to the market's growth.In conclusion, the Digestives & Intestinal Remedies market in Georgia is developing due to changing customer preferences towards natural remedies, emerging trends such as probiotics and digestive enzymes, local special circumstances that promote the use of natural remedies, and underlying macroeconomic factors such as economic growth and increased consumer spending. This market is expected to continue growing as consumers prioritize their digestive health and seek effective and safe solutions.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights